A detailed history of Compass Wealth Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Compass Wealth Management LLC holds 264 shares of EW stock, worth $18,197. This represents 0.01% of its overall portfolio holdings.

Number of Shares
264
Holding current value
$18,197
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$84.3 - $94.31 $22,255 - $24,897
264 New
264 $24.4 Million
Q3 2023

Oct 25, 2023

BUY
$69.28 - $93.38 $18,289 - $24,652
264 New
264 $18.3 Million
Q4 2022

Feb 17, 2023

BUY
$68.3 - $87.44 $28,276 - $36,200
414 New
414 $30.9 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $42.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Compass Wealth Management LLC Portfolio

Follow Compass Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Compass Wealth Management LLC with notifications on news.